Search results :

Levetiracetam

More information: STITCH, PubChem (stereo-specific compound: 1) and possibly Wikipedia

ATC Code: N03AX14

Side effects

Options: Hide MedDRA Preferred Terms ,   display all 86 labels

MedDRA Preferred Term Side effect Data for drug Placebo Labels
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20
Injury Accidental injury 10.3% - 17% 10% - 16.5% x x x x x x
Vomiting Vomiting 2.2% - 15% 2% - 13% x x x x x x x x x x x x x x x
Headache Headache 1.19% - 19% 0.57% - 15% x x x x x x x x x x x x x x x x x x x x
Nasopharyngitis Nasopharyngitis common, 7% - 15% 5% - 12% x x x x x x x x x x x x x x
Common cold x x
Rhinorrhoea
Infection Infection 13% - 13.2% 7.4% - 8% x x x x x x x x x x x x x x x x x x x x
Somnolence Somnolence 1.67% - 23% 0% - 11% x x x x x x x x x x x x x x x x x x x x
Drowsiness
Aggression Aggression postmarketing, 10% 5% x x x x x x x x x x
Asthenia Fatigue very common, 10% - 15% 5% - 10% x x x x x x x x x x x x x x x
Asthenia 1.3% - 15% 0% - 10% x x x x x x x x x x x x x x x x x x x x
Fatigue Fatigue very common, 10% - 15% 5% - 10% x x x x x x x x x x x x x x x
Cough Cough 9% - 11% 5% - 7% x x x x x x x x x
Cough increased 2% - 11% 1% - 7% x x x x x x x x x x x x x x x x x
Nasal congestion Nasal congestion 9% 2% x x x x x x x x
Abdominal pain upper Abdominal pain upper 9% 8% x x x x x x x x
Diarrhoea Diarrhoea 4.2% - 8% 5% - 7% x x x x x x x x x x x x x x x x x
Gastrointestinal disorder Gastrointestinal disorder 8% 7% x x x x x x x x x x x x
Personality disorder Personality disorder common, 8% 7% x x x x x x x
Decreased appetite Decreased appetite 8% 2% x x x x x x x x
Anorexia 2.4% - 13% 2% - 8% x x x x x x x x x x x x x x x x x x
Dizziness Dizziness 1% - 9.2% 0% - 5% x x x x x x x x x x x x x x x x x x x x
Pain Pain 6% - 7% 3% - 6.6% x x x x x x x x x x x x x x x x x
Pharyngitis Pharyngitis 5.7% - 10% 0% - 8% x x x x x x x x x x x x x x x x x x x
Abnormal behaviour Abnormal behaviour postmarketing, 7% 4% x x x x x x x x x x
Laryngeal pain Pharyngolaryngeal pain 7% 4% x x x x x x x x
Irritability Irritability postmarketing — 1.67% - 12% 0% - 2% x x x x x x x x x x x x x x x x
Lethargy Lethargy 6% 2% x x x x x x x x x
Agitation Agitation 4% - 6% 1% x x x x x x x x x x x x x
Hyperkinesia x x x x x x x
Eczema Eczema common x x x x x x x x x x x x x
Nausea Nausea 4.2% - 5% 3% - 4.6% x x x x x x x x
Myalgia Myalgia common x x x x x x x x x x x x x
Musculoskeletal discomfort Myalgia common x x x x x x x x x x x x x
Arthralgia 2% 0% x x x x x x x x x x x x x
Disturbance in attention Disturbance in attention common x x x x x x x x x x x x x
Memory impairment Memory impairment common x x x x x x x x x x x x x
Vision blurred Vision blurred common x x x x x x x x x x x x x
Balance disorder Balance disorder common x x x x x x x x x x x x x
Influenza Influenza 3% - 8% 1% - 6% x x x x x x x x x x x x x x x x x x
Albuminuria Albuminuria 4% 0% x x x x
Back pain Back pain 4% 4.6% x x x x x x
Depression Depression 1.67% - 5% 0% - 2.3% x x x x x x x x x x x x x x x x x x x
Ecchymosis Ecchymosis 1.5% - 4% 1% - 1.1% x x x x x x x
Gastroenteritis Gastroenteritis 1.2% - 4% 0% - 2% x x x x x x x x x x x x x
Head injury Head injury 4% 0% x x x x x x x x
Nervousness Nervousness 1.67% - 10% 0% - 2% x x x x x x x x x x x x x x x x x x x x
Tension Nervousness 1.67% - 10% 0% - 2% x x x x x x x x x x x x x x x x x x x x
Rhinitis Rhinitis 2% - 13% 0% - 8% x x x x x x x x x x x x x x x x x x
Common cold x x
Abdominal pain Abdominal pain 3.7% 5.1% x x x x x x x
Gastrointestinal pain Abdominal pain 3.7% 5.1% x x x x x x x
Ataxia Ataxia 2.5% - 3% 1% - 1.4% x x x x x x x x x x x x x x x x x x x x
Constipation Constipation 3% 1% x x x x x x x x x x x x x x
Contusion Contusion 3% 1% x x x x x x x x
Vertigo Vertigo 2.5% - 5% 1% - 3% x x x x x x x x x x x x x x x x x x x
Mood swings Mood swings common, 1.6% - 6% 0% - 4% x x x x x x x x x x x x x x x x x x x
Affect lability Mood swings common, 1.6% - 6% 0% - 4% x x x x x x x x x x x x x x x x x x x
Affect lability 2% 1% x x x x x x x x x
Coordination abnormal Coordination abnormal 3% 2% x x x x x x x x x x
Convulsion Convulsion 2.38% - 6% 2.85% - 6.8% x x x x x x
Dyspepsia Dyspepsia 2.8% 3.4% x x x x x x x
Amblyopia Amblyopia 1.2% - 2% 0% - 1.4% x x x x x x
Amnesia Amnesia 1.6% - 2% 0.3% - 1% x x x x x x x x x x x x x x x x x x x
Anxiety Anxiety 1.6% - 3.33% 1% - 2% x x x x x x x x x x x x x x x x x x x
Arthralgia Arthralgia 2% 0% x x x x x x x x x x x x x
Asthma Asthma 2% 1% x x x x
Neck pain Neck pain 2% - 8% 1% - 2% x x x x x x x x x x x x x x x x
Confusional state Confusional state postmarketing, 2% 0% x x x x x x x x x x x x x x x
Feeling abnormal Confusional state postmarketing, 2% 0% x x x x x x x x x x x x x x x
Conjunctivitis Conjunctivitis 2% - 3% 0% - 2% x x x x x x x x x x x x
Dehydration Dehydration 2% 1% x x x x
Diplopia Diplopia 1.67% - 2.4% 0% - 1.7% x x x x x x x x x x x x x x x x x x
Ear pain Ear pain 2% 0% - 1% x x x x x x x x x x x x
Hostility Hostility 2% - 12% 0.6% - 6% x x x x x x x x x x x x x x x x x x x x
Paraesthesia Paraesthesia 1.9% - 2% 1% - 1.7% x x x x x x x x x x x x x x x x x x
Pruritus Pruritus common, 2% 0% x x x x x
Sinusitis Sinusitis 2% - 2.1% 0.9% - 1% x x x x x x x x x x x x x x x x x x x
Viral infection Viral infection 2% 1% x x x x
Rash pustular Vesiculobullous rash 2% 0% x x x x
Dermatitis bullous Vesiculobullous rash 2% 0% x x x x
Hyperreflexia Hyperreflexia 2% 1% x x x x
Skin discolouration Skin discolouration 2% 0% x x x x
Urine abnormality Urine abnormality 2% 1% x x x x
Urine analysis abnormal Urine abnormality 2% 1% x x x x
Depressed mood Depressed mood 1.67% - 2% 0% x x x x x x x x x x x x x
Ligament sprain Joint sprain 2% 1% x x x x x x x x
Face oedema Face oedema 2% 1% x x x x
Hypersomnia Hypersomnia 1.67% - 2% 0% x x x x x x x x x x x x x
Insomnia Insomnia 1.67% - 5% 0% - 3% x x x x x x x x x x x x x x x x x x
Urinary tract infection Urinary tract infection 1.9% 3.4% x x x x x x
Tooth disorder Tooth disorder 1.5% 0.6% x x
Tremor Tremor 1.5% 1.7% x x x x x x x
Thinking abnormal Thinking abnormal 1.5% 1.4% x x x x x x x x
Mental disability Thinking abnormal 1.5% 1.4% x x x x x x x x
Bronchitis Bronchitis 1.3% 1.4% x x x x x x
Chest pain Chest pain 1.3% 1.1% x x x x x x
Body temperature increased Body temperature increased 1.3% 1.7% x x x x x x
Drug level increased Drug level increased 1.3% 0.9% x x x x x x
Gingivitis Gingivitis 1.2% 0.6% x x x x x x
Otitis media Otitis media 1.2% 0.9% x x x x x x
Weight increased Weight increased 1.2% 1.1% x x x x x x
Psychotic disorder Psychotic disorder postmarketing, 1% 0% x
Agranulocytosis Agranulocytosis postmarketing x x
Alopecia Alopecia postmarketing x x x x x x x x x x x x x x x x x
Anger Anger postmarketing x x
Mental disorder Mental disorder postmarketing x x x x x x x x x x x x x x x x x
Dyskinesia Dyskinesia postmarketing x x x x x x x x
Eosinophilia Eosinophilia postmarketing x
Toxic epidermal necrolysis Toxic epidermal necrolysis postmarketing x
Erythema multiforme Erythema multiforme postmarketing x x x x x x x x x x x
Stevens-Johnson syndrome postmarketing x
Hallucination Hallucination postmarketing x x
Blood disorder Blood disorder postmarketing x
Hepatitis Hepatitis postmarketing x x x x x x x x x x x x x x x x
Hyponatraemia Hyponatraemia postmarketing x
Leukopenia Leukopenia postmarketing x x x x x x x x x x x x x x x x x x
Nervous system disorder Nervous system disorder postmarketing x x x x x x x x x x x x x x x
Neutropenia Neutropenia postmarketing x x x x x x x x x x x x x x x x x x
Pancreatitis Pancreatitis postmarketing x x x x x x x x x x x x x x x x x
Pancytopenia Pancytopenia postmarketing x x x x x x x x x x x x x x x x x x
Stevens-Johnson syndrome Stevens-Johnson syndrome postmarketing x
Completed suicide Suicide postmarketing x x
Completed suicide postmarketing x x x x
Suicide attempt Suicide attempt postmarketing x x
Thrombocytopenia Thrombocytopenia postmarketing, common x x x x x x x x x x x x x x x x x x
Weight decreased Weight decreased postmarketing x x x x x x x x x x x x x x x x
Choreoathetosis Choreoathetosis postmarketing x x x x x x x x x
Hepatic failure Hepatic failure postmarketing x x x x x x x x x x x x x x x
Panic attack Panic attack postmarketing x x x x x x
Liver function test abnormal Liver function test abnormal postmarketing x x x x x x x x x x x x x x x x
Raised liver function tests postmarketing
Muscular weakness Muscular weakness postmarketing x x x x x x
Malnutrition Malnutrition postmarketing x x x x x x x x x x
Suicidal ideation Suicidal ideation postmarketing x x
Drug interaction Drug interaction postmarketing
Suicidal behaviour Suicidal behaviour postmarketing x x x x x x x x x x
Connective tissue disorder Connective tissue disorder x x x x x x x x x x x x x x x
Depersonalisation Depersonalisation
Drug abuse Drug abuse
Dysmenorrhoea Dysmenorrhoea
Epistaxis Epistaxis x x x x x
Dermatitis Rash 0% - 2.8% 1.14% - 4% x x x x x x x x x
Rash Rash 0% - 2.8% 1.14% - 4% x x x x x x x x x
Eye disorder Eye disorder x x x x x x x x x x
Hypersensitivity Hypersensitivity x x x x x
Immune system disorder Immune system disorder
Liver disorder Liver disorder
Hepatocellular injury Liver disorder
Foetor hepaticus Liver disorder
Mediastinal disorder Mediastinal disorder x x x x x x x x x
Metabolic disorder Metabolic disorder
Fungal infection Fungal infection x x x x x
Neurosis Neurosis
Pregnancy Pregnancy x x x x x x x x x x
Skin disorder Skin disorder
Unspecified disorder of skin and subcutaneous tissue x
Status epilepticus Status epilepticus x x x x x
Toothache Toothache
Upper respiratory tract infection Upper respiratory tract infection x x
Urinary incontinence Urinary incontinence x x x x x
Apathy Apathy
Flat affect Apathy
Lower respiratory tract infection Lower respiratory tract infection x
Stomatitis Mouth ulceration x
Mouth ulceration Mouth ulceration x
Paranoia Paranoid reaction
Community acquired infection Community acquired infection x
Renal impairment Function kidney decreased
Teratogenicity Teratogenicity
Psychiatric symptom Psychiatric symptom x x x x x x x
Antisocial personality disorder Antisocial behaviour
Antisocial behaviour Antisocial behaviour
Asocial behaviour Antisocial behaviour
Drug withdrawal convulsions Withdrawal seizures x x x x x x x x x
Euphoric mood Euphoric mood
Oropharyngeal discomfort Throat sore
Oropharyngeal pain Throat sore
Hepatobiliary disease Hepatobiliary disease x
Major depression Psychotic depression
Hyperkinesia Hyperkinesia x x x x x x x
Progesterone Progesterone levels
Dependence Dependence
Gait disturbance Gait disturbance
White blood cell count decreased White blood cell count decreased x
Infestation Infestation NOS x x x x x x x x x x x x x x x
Procedural complication Procedural complication
Respiratory failure Respiratory failure x
Rhinorrhoea Rhinorrhoea

Indications

Information about indications was extracted from the indications and usage sections of the labels.

LEVETIRACETAM / APO-LEVETIRACETAM

Side effects:30
Source:Health Canada

LEVETIRACETAM

Side effects:45
Source:FDA Structured Product Label

LEVETIRACETAM

Side effects:46
Source:FDA Structured Product Label

LEVETIRACETAM / KEPPRA

Side effects:49
Source:FDA

LEVETIRACETAM

Side effects:51
Source:FDA Structured Product Label

LEVETIRACETAM

Side effects:58
Source:FDA Structured Product Label

levetiracetam

Side effects:63
Source:FDA Structured Product Label

LEVETIRACETAM

Side effects:77
Source:FDA Structured Product Label

LEVETIRACETAM / KEPPRA

Side effects:77
Source:FDA

levetiracetam / levetiracetam

Side effects:78
Source:EMA

LEVETIRACETAM

Side effects:81
Source:FDA Structured Product Label

LEVETIRACETAM

Side effects:83
Source:FDA Structured Product Label

LEVETIRACETAM

Side effects:83
Source:FDA Structured Product Label

LEVETIRACETAM

Side effects:84
Source:FDA Structured Product Label

LEVETIRACETAM

Side effects:85
Source:FDA Structured Product Label

LEVETIRACETAM

Side effects:85
Source:FDA Structured Product Label

LEVETIRACETAM

Side effects:85
Source:FDA Structured Product Label

levetiracetam

Side effects:88
Source:FDA Structured Product Label

LEVETIRACETAM / KEPPRA

Side effects:89
Source:FDA

Levetiracetam / LEVETIRACETAM TABLETS

Side effects:103
Source:medicines.org.au

Color scheme:

standard – alternative

    100%
    75%
    50%
    10%
    frequent (1% to 100%)
    infrequent (0.1% to 1%)
    rare (<0.1%)
    postmarketing
    0%
    no frequency information
    not found on label